Extragonadal teratoma

Summary

Extragonadal teratoma (MONDO:0019500) is a disease. A subtype of extragonadal non-dysgerminomatous germ cell tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	extragonadal teratoma
Mondo ID	MONDO:0019500
Orphanet	883
NCIT	C189045
SNOMED CT	768937006
UMLS	C4708601
MedGen	1646497
GARD	0018711
MedDRA	10043276
Is cancer (heuristic)	no

Data availability: 2 cell lines.

Disease family

An umbrella term covering 3 Mondo subtypes.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › extragonadal germ cell tumor › extragonadal non-dysgerminomatous germ cell tumor › extragonadal teratoma

Related subtypes (3): mediastinum teratoma, extragonadal nonseminomatous germ cell tumor, central nervous system nongerminomatous germ cell tumor

Subtypes (3): central nervous system teratoma, epignathus, nasopharyngeal teratoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.